Amedeo Smart

Free Medical Literature Service

 

Amedeo

Alzheimer's Disease
  Free Subscription

Articles published in
Neurosci Lett
    April 2024
  1. XIANG X, Xia S, Li S, Zeng Y, et al
    Study on the role and mechanism of Tan IIA in Alzheimer's disease based on CREB-BDNF-TrkB pathway.
    Neurosci Lett. 2024;830:137769.
    >> Share

  2. ZHANG Y, Wu F
    Diagnostic value and cognitive regulatory roles of long non-coding RNA UCA1 in Alzheimer's disease.
    Neurosci Lett. 2024 Apr 5:137765. doi: 10.1016/j.neulet.2024.137765.
    >> Share

    March 2024
  3. CHEN J, Su C, Ma Z, Ou X, et al
    Aerobic exercise suppresses cognitive injury in patients with Alzheimer's disease by regulating long non-coding RNA TUG1.
    Neurosci Lett. 2024;826:137732.
    >> Share

  4. FENG Q, Li X, Liu R, Liu G, et al
    Overexpression of MTMR14 induced learning and memory impairments in 2-month-old C57 mice.
    Neurosci Lett. 2024;825:137700.
    >> Share

    February 2024
  5. SHIGEMATSU K, Komori N, Ideno M, Yamagishi H, et al
    "Evaluation of neprilysin activity in Adipose-Derived stem cells from Alzheimer's disease patients".
    Neurosci Lett. 2024;825:137705.
    >> Share

  6. HUANG W, Chen Q, Zhou P, Ye S, et al
    Neuroprotective effect of chrysophanol in Alzheimer disease via modulating the Ca(2+)/EGFR-PLCgamma pathway.
    Neurosci Lett. 2024 Feb 12:137684. doi: 10.1016/j.neulet.2024.137684.
    >> Share

  7. CAKIR M, Sacmaci H
    The relationship of salusins with Parkinson's Disease, Alzheimer's Disease, and acute ischemic stroke: A preliminary study.
    Neurosci Lett. 2024 Feb 11:137683. doi: 10.1016/j.neulet.2024.137683.
    >> Share

  8. KAAR A, Weir MP, Rae MG
    Altered neuronal group 1 metabotropic glutamate receptor- and endoplasmic reticulum-mediated Ca(2+) signaling in two rodent models of Alzheimer's disease.
    Neurosci Lett. 2024;823:137664.
    >> Share

    January 2024
  9. XIE YH, Jiang L, Zhang Y, Deng YH, et al
    Antagonizing LINGO-1 reduces activated microglia and alleviates dendritic spine loss in the hippocampus of APP/PS1 transgenic mice.
    Neurosci Lett. 2024;820:137612.
    >> Share

  10. ROBBIE L, Fernandez SG, Montoya L, Sagare A, et al
    Age of onset predicted by Abeta profiling in a novel PSEN1 (I180F) mutation.
    Neurosci Lett. 2024;820:137591.
    >> Share

  11. CHEN TJ, Hung HS, Cheng TL, Wang DC, et al
    Histone deacetylase inhibitor attenuates the effects of 27-hydroxycholesterol on the rat brain.
    Neurosci Lett. 2024;818:137533.
    >> Share

    December 2023
  12. ZHANG Y, Shen S, Li X, Wang S, et al
    A multiclass extreme gradient boosting model for evaluation of transcriptomic biomarkers in Alzheimer's disease prediction.
    Neurosci Lett. 2023;821:137609.
    >> Share

    November 2023
  13. LIU L, Liu L, Lu Y, Zhang T, et al
    GDP dissociation inhibitor 1 (GDI1) attenuates beta-amyloid-induced neurotoxicity in Alzheimer's diseases.
    Neurosci Lett. 2023;818:137564.
    >> Share

  14. ZARIFKAR AH, Zarifkar A, Safaei S
    Different paradigms of transcranial electrical stimulation induce structural changes in the CA1 region of the hippocampus in a rat model of Alzheimer's disease.
    Neurosci Lett. 2023 Nov 22:137570. doi: 10.1016/j.neulet.2023.137570.
    >> Share

  15. GUO F, Kang J, Xu J, Wei S, et al
    Genome-wide identification of m(6)A-associated single nucleotide polymorphisms in complex diseases of nervous system.
    Neurosci Lett. 2023;817:137513.
    >> Share

  16. ZHANG J, Guo S, Tao R, Wang F, et al
    Neuroprotective effect of plasmalogens on AlCl(3)-induced Alzheimer's disease zebrafish via acting on the regulatory network of ferroptosis, apoptosis and synaptic neurotransmission release with oxidative stress as the center.
    Neurosci Lett. 2023;818:137560.
    >> Share

    October 2023
  17. GHOLAMI A
    Alzheimer's disease: The role of proteins in formation, mechanisms, and new therapeutic approaches.
    Neurosci Lett. 2023;817:137532.
    >> Share

  18. KISHORE N, Goel N
    Deep learning based diagnosis of Alzheimer's disease using FDG-PET images.
    Neurosci Lett. 2023 Oct 17:137530. doi: 10.1016/j.neulet.2023.137530.
    >> Share

    September 2023
  19. KAMRANFAR F, Jaktaji RP, Shirani K, Jamshidi A, et al
    Protective effect of a standardized Allium jesdianum extract in an Alzheimer's disease induced rat model.
    Neurosci Lett. 2023 Sep 19:137491. doi: 10.1016/j.neulet.2023.137491.
    >> Share

    August 2023
  20. KARIMI-ZANDI L, Ghorbandaiepour T, Zahmatkesh M
    The increment of annexin V-positive microvesicles versus annexin V-negative microvesicles in CSF of an animal model of Alzheimer's disease.
    Neurosci Lett. 2023;814:137446.
    >> Share

  21. BUDHBHATTI U, Joshi C, Chauhan A, Bhatt D, et al
    Association of NOTCH4 and ACHE gene polymorphism in Alzheimer's disease of Gujarat cohort.
    Neurosci Lett. 2023 Aug 4:137428. doi: 10.1016/j.neulet.2023.137428.
    >> Share

    July 2023
  22. KUO YY, Chen WT, Lin GB, Chen YM, et al
    Thermal cycling-hyperthermia ameliorates Abeta(25-35)-induced cognitive impairment in C57BL/6 mice.
    Neurosci Lett. 2023;810:137337.
    >> Share

  23. ABOLHASANI F, Pourshojaei Y, Mohammadi F, Esmaeilpour K, et al
    Exploring the potential of a novel phenoxyethyl piperidine derivative with cholinesterase inhibitory properties as a treatment for dementia: Insights from STZ animal model of dementia.
    Neurosci Lett. 2023;810:137332.
    >> Share

  24. SHAJI S, Palanisamy R, Swaminathan R
    Structural irregularities in MR corpus callosal images and their association with cerebrospinal fluid biomarkers in Mild Cognitive Impairments.
    Neurosci Lett. 2023;810:137329.
    >> Share

    June 2023
  25. NAKANISHI K, Norimatsu K, Tani A, Matsuoka T, et al
    Effects of early exercise intervention and exercise cessation on neuronal loss and neuroinflammation in a senescence-accelerated mouse prone 8.
    Neurosci Lett. 2023;808:137297.
    >> Share

  26. CHEN L, Wang L, Zhou GF, Liu Y, et al
    TNIP2 inhibits amyloidogenesis by regulating the 3'UTR of BACE1: An in vitro study.
    Neurosci Lett. 2023;808:137265.
    >> Share

  27. WANG M, Zhao H, Zhang Z, Zhao Z, et al
    Down-regulating insulin-like growth factor-1 receptor reduces amyloid-beta deposition in mice cortex induced by chronic sleep restriction.
    Neurosci Lett. 2023;808:137189.
    >> Share

  28. HAMSAFAR Y, Chen Q, Borowsky AD, Beach TG, et al
    Biochemical analyses of tau and other neuronal markers in the submandibular gland and frontal cortex across stages of Alzheimer's disease.
    Neurosci Lett. 2023 Jun 15:137330. doi: 10.1016/j.neulet.2023.137330.
    >> Share

  29. DELVENNE JF, Scally B, Rose Burke M
    Splenium tract projections of the corpus callosum to the parietal cortex classifies Alzheimer's disease and mild cognitive impairment.
    Neurosci Lett. 2023;810:137331.
    >> Share

    April 2023
  30. DONG L, Chang Q, Ma J, Liu C, et al
    Associations of blood UCH-L1 and NfL levels with cognitive dysfunction in Parkinson's disease patients.
    Neurosci Lett. 2023;804:137219.
    >> Share

  31. RODRIGUEZ JJ, Terzieva S, Yeh CY, Gardenal E, et al
    Neuroanatomical and morphometric study of S100beta positive astrocytes in the entorhinal cortex during ageing in the 3xTg-Alzehimer's disease mouse model.
    Neurosci Lett. 2023;802:137167.
    >> Share

  32. CAI Y, Fu P, Zhang X
    Association of plasma phosphor-tau181 with Abeta levels may vary by APOE epsilon4 status and sex among non-demented old adults.
    Neurosci Lett. 2023;802:137161.
    >> Share

  33. SOMERA B, Frick M, Fadel JR
    Age-related changes in basal forebrain afferent activation in response to food paired stimuli.
    Neurosci Lett. 2023;802:137155.
    >> Share

    March 2023
  34. XIONG L, Wang Z
    BMP9 ameliorates amyloid pathology by promoting low-density lipoprotein receptor-related protein 1 expression in APP/PS1 transgenic mice.
    Neurosci Lett. 2023;801:137159.
    >> Share

  35. WANG P, Wang X, Qiao K, Zhang Y, et al
    Reduced SUMOylation of Nrf2 signaling contributes to its inhibition induced by amyloid-beta.
    Neurosci Lett. 2023;799:137118.
    >> Share

  36. SINGH L, Singh S
    Neuroprotective potential of Honokiol in ICV-STZ induced neuroinflammation, Abeta ((1-42)) and NF-kB expression in experimental model of rats.
    Neurosci Lett. 2023;799:137090.
    >> Share

  37. LI H, Zhang D, Wang X, Wang S, et al
    Protective effect of glutamic-oxaloacetic transaminase on hippocampal neurons in Alzheimer's disease using model mice.
    Neurosci Lett. 2023;803:137194.
    >> Share

  38. WEI R, He JQ, Chen WH, Tam KY, et al
    Evaluations of the neuroprotective effects of a dual-target isoquinoline inhibitor in the triple transgenic mouse model of Alzheimer's disease.
    Neurosci Lett. 2023 Mar 6:137166. doi: 10.1016/j.neulet.2023.137166.
    >> Share

    February 2023
  39. ZHANG J, Zhao Y, Zhang Y, Gao Y, et al
    Alpha lipoic acid treatment in late middle age improves cognitive function: Proteomic analysis of the protective mechanisms in the hippocampus.
    Neurosci Lett. 2023;798:137098.
    >> Share

  40. PEREZ-GARCIA G, Bicak M, Haure-Mirande JV, Perez GM, et al
    BCI-838, an orally active mGluR2/3 receptor antagonist pro-drug, rescues learning behavior deficits in the PS19 MAPT(P301S) mouse model of tauopathy.
    Neurosci Lett. 2023;797:137080.
    >> Share

  41. WANG S, Ke S, Liu S, Wang E, et al
    APOE epsilon4 status and plasma p-tau181 interact to influence cognitive performance among non-demented older adults.
    Neurosci Lett. 2023;796:137052.
    >> Share

    January 2023
  42. KUMAR A, Verma A, Chaurasia RN
    Vitamin D and inflammatory cytokines association in mild cognitive impaired subjects.
    Neurosci Lett. 2023;795:137044.
    >> Share

  43. RAMIREZ-HERNANDEZ E, Sanchez-Maldonado C, Patricio-Martinez A, Limon ID, et al
    Amyloid-beta (25-35) induces the morphological alteration of dendritic spines and decreases NR2B and PSD-95 expression in the hippocampus.
    Neurosci Lett. 2023;795:137030.
    >> Share

  44. DAS S, Datta S, Ghosal A, Chaudhuri NR, et al
    Screening of BACE1 inhibitors with antiamyloidogenic activity: A study of flavonoids and flavonoid derivatives.
    Neurosci Lett. 2023;792:136965.
    >> Share

    November 2022
  45. XIA S, Zhang Y, Peng B, Hu X, et al
    Detection of mild cognitive impairment in type 2 diabetes mellitus based on machine learning using privileged information.
    Neurosci Lett. 2022;791:136908.
    >> Share

  46. FARHANGIAN M, Azarafrouz F, Chavoshinezhad S, Dargahi L, et al
    Intranasal interferon-beta alleviates anxiety and depressive-like behaviors by modulating microglia polarization in an Alzheimer's disease model.
    Neurosci Lett. 2022 Nov 14:136968. doi: 10.1016/j.neulet.2022.136968.
    >> Share

  47. FOLORUNSO OO, Harvey TL, Brown SE, Chelini G, et al
    The D-serine biosynthetic enzyme serine racemase is expressed by reactive astrocytes in the amygdala of human and a mouse model of Alzheimer's disease.
    Neurosci Lett. 2022;792:136958.
    >> Share

    October 2022
  48. SHEN Q, Patten KT, Valenzuela A, Lein PJ, et al
    Probing changes in brain esterified oxylipin concentrations during the early stages of pathogenesis in Alzheimer's Disease transgenic rats.
    Neurosci Lett. 2022 Oct 18:136921. doi: 10.1016/j.neulet.2022.136921.
    >> Share

  49. RAFIEY M, Nosrati R, Babaei P
    Protective effect of miR-34c antagomir against STZ-induced memory impairment by targeting mTOR and PSD-95 in the hippocampus of rats.
    Neurosci Lett. 2022;789:136881.
    >> Share

    September 2022
  50. WANG Y, Lv S, Zhou X, Niu X, et al
    Identification of hsa-miR-365b-5p's role in Alzheimer's disease: A combined analysis of miRNA and mRNA microarrays.
    Neurosci Lett. 2022;790:136892.
    >> Share

  51. LANG W, Li X, Wang Y, Duan Y, et al
    Sodium propionate improves cognitive and memory function in mouse models of Alzheimer's disease.
    Neurosci Lett. 2022 Sep 26:136887. doi: 10.1016/j.neulet.2022.136887.
    >> Share

  52. TONDELLI M, Salemme S, Vinceti G, Bedin R, et al
    Predictive value of phospho-tau/total-tau ratio in amyloid-negative Mild Cognitive Impairment.
    Neurosci Lett. 2022;787:136811.
    >> Share

    August 2022
  53. LONG Y, Cheng Y, Yang J, Yang T, et al
    Abeta-induced presynaptic release of UBC9 through extracellular vesicles involves SNAP23.
    Neurosci Lett. 2022;785:136771.
    >> Share

    July 2022
  54. RONG Y, Mi X, Ni C, Liu T, et al
    Protective effect of vitamin C on DNA damage in surgery-induced cognitive dysfunction in APP/PS1 mice.
    Neurosci Lett. 2022;784:136740.
    >> Share

  55. LIN J, Niu Z, Xue Y, Gao J, et al
    Chronic vitamin D3 supplementation alleviates cognition impairment via inhibition of oxidative stress regulated by PI3K/AKT/Nrf2 in APP/PS1 transgenic mice.
    Neurosci Lett. 2022;783:136725.
    >> Share

  56. KOCA S, Kiris I, Sahin S, Cinar N, et al
    Decreased levels of cytokines implicate altered immune response in plasma of moderate-stage Alzheimer's disease patients.
    Neurosci Lett. 2022 Jul 13:136799. doi: 10.1016/j.neulet.2022.136799.
    >> Share

  57. ZHANG Y, Liu D, Yao X, Wen J, et al
    DMTHB ameliorates memory impairment in Alzheimer's disease mice through regulation of neuroinflammation.
    Neurosci Lett. 2022 Jul 7:136770. doi: 10.1016/j.neulet.2022.136770.
    >> Share

    June 2022
  58. WANG J, Wen C, Li J, Chen J, et al
    Automated quantification of brain connectivity in Alzheimer's disease using ClusterMetric.
    Neurosci Lett. 2022 Jun 10:136724. doi: 10.1016/j.neulet.2022.136724.
    >> Share

  59. MA X, Liu L, Meng J
    Retraction notice to "MicroRNA-125b promotes neurons cell apoptosis and tau phosphorylation in Alzheimer's disease" [Neurosci. Lett. 661 (2017) 57-62].
    Neurosci Lett. 2022;783:136703.
    >> Share

  60. AAMERI R, Ghorbani H, Reza Bazrafshan H, Zahra Gharib F, et al
    Iranian thyme honey plays behavioral, cellular and molecular important roles as an amazing preventive and therapeutic agent in the brain of Alzheimer's rat model.
    Neurosci Lett. 2022;783:136702.
    >> Share

    May 2022
  61. HU Y, Wen C, Cao G, Wang J, et al
    Brain network connectivity feature extraction using deep Learning for Alzheimer's disease classification.
    Neurosci Lett. 2022 May 2:136673. doi: 10.1016/j.neulet.2022.136673.
    >> Share

    April 2022
  62. WANG Y, Yang Y, Liu Y, Guo A, et al
    Cognitive impairments in type 1 diabetes mellitus model mice are associated with synaptic protein disorders.
    Neurosci Lett. 2022;777:136587.
    >> Share

    February 2022
  63. PIJEWSKI RS, Sutter PA, Duszak VA, Singh N, et al
    Distinct profiles of cellular senescence-associated gene expression in the aged, diseased or injured central nervous system.
    Neurosci Lett. 2022;772:136480.
    >> Share

  64. LI Y, Han X, Fan H, Sun J, et al
    Circular RNA AXL increases neuron injury and inflammation through targeting microRNA-328 mediated BACE1 in Alzheimer's disease.
    Neurosci Lett. 2022 Feb 12:136531. doi: 10.1016/j.neulet.2022.136531.
    >> Share

  65. AN Y, Qi Y, Li Y, Li Z, et al
    Activation of the sigma-1 receptor attenuates blood-brain barrier disruption by inhibiting amyloid deposition in Alzheimer's disease mice.
    Neurosci Lett. 2022 Feb 11:136528. doi: 10.1016/j.neulet.2022.136528.
    >> Share

    January 2022
  66. IMA X, Liu L, Meng J
    Expression of concern: MicroRNA-125b promotes neurons cell apoptosis and tau phosphorylation in Alzheimer's disease.
    Neurosci Lett. 2022;769:136229.
    >> Share

  67. CHENFEI Z, Haizhen Y, Jie X, Na Z, et al
    Effects of aerobic exercise on hippocampal SUMOylation in APP/PS1 transgenic mice.
    Neurosci Lett. 2022;767:136303.
    >> Share

  68. QIAN C, Zhang M
    RTN3 - ASC interaction: The potential mechanism behind diabetes-induced cortical neuritic dystrophy.
    Neurosci Lett. 2022;766:136333.
    >> Share

    December 2021
  69. XUE YY, Chen YH, Lin RR, Huang HF, et al
    Alzheimer's disease susceptibility locus in CD2AP is associated with increased cerebrospinal fluid tau levels in mild cognitive impairment.
    Neurosci Lett. 2021 Dec 24:136419. doi: 10.1016/j.neulet.2021.136419.
    >> Share

  70. WANG M, Ren Q, Shi Y, Shu H, et al
    The Effect of Alzheimer's Disease Risk Factors on Brain Aging in normal Chineses: Cognitive Aging and Cognitive Reserve.
    Neurosci Lett. 2021 Dec 16:136398. doi: 10.1016/j.neulet.2021.136398.
    >> Share

  71. LAI X, Hu J, Liu H, Lan L, et al
    A short peptide from sAPPalpha binding to BACE1-APP action site rescues Alzheimer-like pathology.
    Neurosci Lett. 2021 Dec 13:136397. doi: 10.1016/j.neulet.2021.136397.
    >> Share

    November 2021
  72. GEORGE B, D Gokhale S, Yaswanth PM, Vijayan A, et al
    Identification of Alzheimer associated differentially expressed gene through microarray data and transfer learning-based image analysis.
    Neurosci Lett. 2021;766:136357.
    >> Share

  73. ZHOU X, Wang Y, Lv S, Li Y, et al
    Transcranial magnetic stimulation for sleep disorders in Alzheimer's disease: A double-blind, randomized, and sham-controlled pilot study.
    Neurosci Lett. 2021;766:136337.
    >> Share

  74. ZHANG Y, Zhao Y, Zhang J, Gao Y, et al
    Ginkgolide B inhibits NLRP3 inflammasome activation and promotes microglial M2 polarization in Abeta1-42-induced microglia cells.
    Neurosci Lett. 2021;764:136206.
    >> Share

    October 2021
  75. ZHU Z, Liu Y, Li X, Zhang L, et al
    GPNMB mitigates Alzheimer's disease and enhances autophagy via suppressing the mTOR signal.
    Neurosci Lett. 2021 Oct 22:136300. doi: 10.1016/j.neulet.2021.136300.
    >> Share

  76. BANG S, Kuen Song J, Shin SW, Hee Lee K, et al
    Human Serum Albumin Fusion Protein as Therapeutics for Targeting Amyloid Beta in Alzheimer's Diseases.
    Neurosci Lett. 2021 Oct 18:136298. doi: 10.1016/j.neulet.2021.136298.
    >> Share

    September 2021
  77. CASTILLO-MARIQUEO L, Gimenez-Llort L
    Kyphosis and bizarre patterns impair spontaneous gait performance in end-of-life mice with Alzheimer's disease pathology while gait is preserved in normal aging.
    Neurosci Lett. 2021 Sep 30:136280. doi: 10.1016/j.neulet.2021.136280.
    >> Share

  78. GAO F, Liu T, Tuo M, Chi S, et al
    The role of orexin in Alzheimer disease: From sleep-wake disturbance to therapeutic target.
    Neurosci Lett. 2021;765:136247.
    >> Share

  79. LU X, Zhang Y, Li H, Jin Y, et al
    Nicotine prevents in vivo Abeta toxicity in Caenorhabditis elegans via SKN-1.
    Neurosci Lett. 2021;761:136114.
    >> Share

  80. KURIMOTO E, Yamada R, Hirakawa T, Kimura H, et al
    Therapeutic Potential of TAK-071, a Muscarinic M1 Receptor Positive Allosteric Modulator with Low Cooperativity, For the Treatment of Cognitive Deficits and Negative Symptoms Associated with Schizophrenia.
    Neurosci Lett. 2021 Sep 9:136240. doi: 10.1016/j.neulet.2021.136240.
    >> Share

  81. RADAGHDAM S, Karamad V, Nourazarian A, Shademan B, et al
    Molecular mechanisms of sex hormones in the development and progression of Alzheimer's disease.
    Neurosci Lett. 2021 Sep 6:136221. doi: 10.1016/j.neulet.2021.136221.
    >> Share

    August 2021
  82. RIZZI L, Balthazar MLF
    Mini-review: The suspected non-Alzheimer's disease pathophysiology.
    Neurosci Lett. 2021 Aug 31:136208. doi: 10.1016/j.neulet.2021.136208.
    >> Share

  83. KIM TA, Chen L, Ge S
    The interplay of neurovasculature and adult hippocampal neurogenesis.
    Neurosci Lett. 2021;760:136071.
    >> Share

  84. WEI X, Xie L, Du P, Zhao Z, et al
    Impacts of DNA methylation on Tau protein related genes in the brains of patients with Alzheimer's Disease.
    Neurosci Lett. 2021 Aug 23:136196. doi: 10.1016/j.neulet.2021.136196.
    >> Share

  85. ZHAO N, Xu B
    The beneficial effect of exercise against Alzheimer's disease may result from improved brain glucose metabolism.
    Neurosci Lett. 2021 Aug 18:136182. doi: 10.1016/j.neulet.2021.136182.
    >> Share

    July 2021
  86. SHENG J, Wang L, Cheng H, Zhang Q, et al
    Strategies for multivariate analyses of imaging genetics study in Alzheimer's disease.
    Neurosci Lett. 2021;762:136147.
    >> Share

  87. YUE L, Liu P, Ma N, Xu Y, et al
    Interaction between extracellular ATP5A1 and LPS alleviates LPS-induced neuroinflammation in mice.
    Neurosci Lett. 2021;758:136005.
    >> Share

  88. AREZOUMANDAN S, Cai X, Kalkarni P, Davis SA, et al
    Hippocampal neurobiology and function in an aged mouse model of TDP-43 proteinopathy in an APP/PSEN1 background.
    Neurosci Lett. 2021;758:136010.
    >> Share

  89. SUN B, Yao J, Chen AW, Estillore JP, et al
    Genetically and pharmacologically limiting RyR2 open time prevents neuronal hyperactivity of hippocampal CA1 neurons in brain slices of 5xFAD mice.
    Neurosci Lett. 2021;758:136011.
    >> Share

  90. WANDER CM, Song J
    The Neurogenic Niche in Alzheimer's disease.
    Neurosci Lett. 2021 Jul 13:136109. doi: 10.1016/j.neulet.2021.136109.
    >> Share

    June 2021
  91. SINGULANI MP, De Paula VJR, Forlenza OV
    Mitochondrial dysfunction in Alzheimer's disease: therapeutic implications of lithium.
    Neurosci Lett. 2021 Jun 20:136078. doi: 10.1016/j.neulet.2021.136078.
    >> Share

  92. HAUSSMANN R, Noppes F, Brandt MD, Bauer M, et al
    Lithium: A therapeutic option in Alzheimer's disease and its prodromal stages?
    Neurosci Lett. 2021 Jun 10:136044. doi: 10.1016/j.neulet.2021.136044.
    >> Share

  93. ANDROVICOVA R, Pfaus JG, Ovsepian SV
    Estrogen Pendulum in Schizophrenia and Alzheimer's Disease: Review of Therapeutic Benefits and Outstanding Questions.
    Neurosci Lett. 2021 Jun 8:136038. doi: 10.1016/j.neulet.2021.136038.
    >> Share

    May 2021
  94. DAINI E, Secco V, Liao W, Zoli M, et al
    A regional and cellular analysis of the early intracellular and extracellular accumulation of Abeta in the brain of 5XFAD mice.
    Neurosci Lett. 2021;754:135869.
    >> Share

  95. HE B, Wang L, Xu B, Zhang Y, et al
    Association between CSF Abeta42 and amyloid negativity in patients with different stage mild cognitive impairment.
    Neurosci Lett. 2021;754:135765.
    >> Share

  96. LAKSHMI S, Raghu SV, Elumalai P, Sivan S, et al
    Alkoxylglycerol enhanced activity of Oxyresveratrol in Alzheimer's disease by rescuing Tau protein.
    Neurosci Lett. 2021 May 20:135981. doi: 10.1016/j.neulet.2021.135981.
    >> Share

  97. ZARETSKY DV, Zaretskaia MV
    Mini-review: Amyloid degradation toxicity hypothesis of Alzheimer's disease.
    Neurosci Lett. 2021;756:135959.
    >> Share

  98. ZHANG H, Ge H, Li K
    Aberrant expression of miR-148a-3p in Alzheimer's disease and its protective role against amyloid-beta induced neurotoxicity.
    Neurosci Lett. 2021 May 9:135953. doi: 10.1016/j.neulet.2021.135953.
    >> Share

  99. SHAMSIPOUR S, Sharifi G, Taghian F
    Impact of interval training with probiotic (L. plantarum / Bifidobacterium bifidum) on passive avoidance test, ChAT and BDNF in the hippocampus of rats with Alzheimer's disease.
    Neurosci Lett. 2021;756:135949.
    >> Share

    April 2021
  100. ARIOZ BI, Tufekci KU, Olcum M, Durur DY, et al
    Proteome profiling of neuron-derived exosomes in Alzheimer's disease reveals hemoglobin as a potential biomarker.
    Neurosci Lett. 2021;755:135914.
    >> Share

  101. OVSEPIAN SV, O'Leary VB, Hoschl C, Zaborszky L, et al
    Integrated Phylogeny of the Human Brain and Pathobiology of Alzheimer's Disease: A Unifying Hypothesis.
    Neurosci Lett. 2021 Apr 13:135895. doi: 10.1016/j.neulet.2021.135895.
    >> Share

  102. GKANATSIOU E, Sahlin C, Portelius E, Johannesson M, et al
    Characterization of monomeric and soluble aggregated Abeta in Down's syndrome and Alzheimer's disease brains.
    Neurosci Lett. 2021 Apr 10:135894. doi: 10.1016/j.neulet.2021.135894.
    >> Share

  103. RASHTIANI S, Goudarzi I, Jafari A, Rohampour K, et al
    Adenosine monophosphate activated protein kinase (AMPK) is essential for the memory improving effect of adiponectin.
    Neurosci Lett. 2021;749:135721.
    >> Share

    February 2021
  104. SANTOS-GIL DF, Arboleda G, Sandoval-Hernandez AG
    Retinoid X Receptor activation promotes re-myelination in a very old triple transgenic mouse model of Alzheimer's disease.
    Neurosci Lett. 2021 Feb 20:135764. doi: 10.1016/j.neulet.2021.135764.
    >> Share

  105. GIL L, Nino SA, Capdeville G, Jimenez-Capdeville ME, et al
    AGING AND ALZHEIMER S DISEASE CONNECTION: NUCLEAR TAU AND LAMIN A.
    Neurosci Lett. 2021 Feb 18:135741. doi: 10.1016/j.neulet.2021.135741.
    >> Share

  106. JOHNSON MD
    Evaluation of fluid channels in the human dura and superior sagittal sinus in older patients.
    Neurosci Lett. 2021;746:135649.
    >> Share

  107. LIM KH, Kim SH, Yang S, Chun S, et al
    Advances in multiplex PCR for Alzheimer's disease diagnostics targeting CDK genes.
    Neurosci Lett. 2021 Feb 15:135715. doi: 10.1016/j.neulet.2021.135715.
    >> Share

  108. XU L, Dong Q, Xu L, Zou W, et al
    The MCP-1 A-2518G polymorphism increases the risk of Alzheimer's disease: a case-control study.
    Neurosci Lett. 2021 Feb 9:135710. doi: 10.1016/j.neulet.2021.135710.
    >> Share

    January 2021
  109. LIANG C, Mu Y, Tian H, Wang D, et al
    MicroRNA-140 silencing represses the incidence of Alzheimer's disease.
    Neurosci Lett. 2021 Jan 30:135674. doi: 10.1016/j.neulet.2021.135674.
    >> Share

  110. ZHANG B, Wu L, Zhu Q, Dong Y, et al
    Donepezil attenuates the development of morphine tolerance in rats with cancer-induced bone pain: the role of cortical N-methyl-D-aspartate receptors.
    Neurosci Lett. 2021 Jan 28:135678. doi: 10.1016/j.neulet.2021.135678.
    >> Share

  111. WANG Y, Sheng H, Zhao J, Guo L, et al
    Changes in the prefrontal cortex after the hippocampus was injected with Abeta25-35 via the P35/P25-CDK5-Tau hyperphosphorylation signaling pathway.
    Neurosci Lett. 2021;741:135453.
    >> Share

  112. DIXIT MP, Rahmatkar SN, Raut P, Umekar MJ, et al
    Evidences for agmatine alterations in Abeta1-42induced memory impairment in mice.
    Neurosci Lett. 2021;740:135447.
    >> Share

    December 2020
  113. WANG J, Guo MN, Liu ZZ, Ma SF, et al
    PGC-1alpha reduces Amyloid-beta deposition in Alzheimer's disease: Effect of increased VDR expression.
    Neurosci Lett. 2020;744:135598.
    >> Share

  114. TIAN Z, Dong Q, Wu T, Guo J, et al
    MicroRNA-20b-5p aggravates neuronal apoptosis induced by beta-Amyloid via down-regulation of Ras homolog family member C in Alzheimer's disease.
    Neurosci Lett. 2020 Dec 2:135542. doi: 10.1016/j.neulet.2020.135542.
    >> Share

    November 2020
  115. SONG X, Chen J, Hou Z, Xie N, et al
    Antimicrobial therapy and the potential mechanisms in Alzheimer's disease.
    Neurosci Lett. 2020 Nov 6:135464. doi: 10.1016/j.neulet.2020.135464.
    >> Share

    May 2020
  116. LIU HJ, Li XY, Chen H, Yu HL, et al
    Identification of susceptibility loci for cognitive impairment in a cohort of Han Chinese patients with Parkinson's disease.
    Neurosci Lett. 2020 May 10:135034. doi: 10.1016/j.neulet.2020.135034.
    >> Share

    April 2020
  117. ACERO G, Garay C, Venegas D, Ortega E, et al
    Novel monoclonal antibody 3B8 specifically recognizes pyroglutamate-modified amyloid beta 3-42 peptide in brain of AD patients and 3xTg-AD transgenic mice.
    Neurosci Lett. 2020;724:134876.
    >> Share

    February 2020
  118. ZHANG Z, Gao W, Wang X, Zhang D, et al
    Geniposide effectively reverses cognitive impairment and inhibits pathological cerebral damage by regulating the mTOR Signal pathway in APPPS1 mice.
    Neurosci Lett. 2020;720:134749.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016